--Myriad Genetics, Inc., a leader in molecular diagnostics testing and precision medicine, announced today the appointment of Brian Donnelly as chief commercial officer, effective May 1, 2025.

Myriad Genetics Names Brian Donnelly as New Chief Commercial Officer Provided by GlobeNewswire Apr 7, 2025 12:00pm. SALT LAKE CITY, April 07, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc.

SALT LAKE CITY, April 07, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics testing and precision medicine, announced today the appointment of Brian ...